Skip to content

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Technical Complications and Salvage of Hepatic Artery Infusion Pumps: An Institutional Experience of 2935 Consecutive Cases.

OBJECTIVE Describe the technical complications of hepatic artery infusion pump (HAIP) placement and characterize salvage rates. SUMMARY BACKGROUND DATA HAIP chemotherapy is an effective tool used in the treatment of hepatic malignancies and has become increasingly adopted at select centers. Much of the safety data is...

Omar A. Zaki, L. Schleimer, H. Kalvin et al. · 0 citations
Open access Sep 2026

Cysteine supplementation reverses immune dysfunction in cancer patients with severe COVID-19

Severe COVID-19 infection in patients with cancer is characterized by a unique pattern of immunologic dysfunction including muted adaptive immune responses. The molecular drivers of immune dysfunction in cancer patients with severe COVID-19 remain unclear, and therapeutic strategies to overcome immune dysfunction in th...

Tiffany Merlinsky, J. Rahman, Wendy Johnson et al. · 0 citations
Aug 2026

Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced Mucosal Melanoma.

PURPOSE Mucosal melanoma (MM) is a rare subtype of melanoma with inferior response rates and outcomes to immunotherapy. Vascular endothelial growth factor (VEGF) signaling may contribute to immune resistance and represents a potential therapeutic target. We evaluated nivolumab plus axitinib in untreated, advanced MM in...

S. Lochrin, H. Kalvin, Monica F. Chen et al. · 0 citations
Open access Sep 2026

Comprehensive analysis of germline pathogenic variants across melanoma

Although a heritable component is implicated in ~10% of melanomas, the prevalence and functional relevance of germline pathogenic variants (gPVs) in unselected patients remains unknown. We evaluated 701 patients with melanoma who underwent tumor-normal MSK-IMPACT sequencing (2015–2023) and germline analysis of ≥76 ca...

S. Lochrin, H. Walch, Y. Kemel et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.